According to a recently published industry analysis report by Future Market Insights, the global market for large molecule bioanalytical testing had sales of US$ 1.3 billion in 2022. By 2033, the market is anticipated to reach US$ 4.7 billion with a CAGR of 12.1%. With a CAGR of 10.9% from 2023 to 2033, the clinical …
Category Archives: Healthcare Trends
Clostridium Diagnostics Market is anticipated to secure a market value worth US$ 7.8 Billion by 2032 | Says FMI Analyst
The global Clostridium Diagnostics Market is anticipated to grow at a CAGR of 12.2% from 2022 to 2032, from US$ 2.5 billion to US$ 7.8 billion. The market demonstrated a CAGR of 13.6% from 2015 to 2021. The increasing incidence of clostridium-related illnesses and the expansion of public awareness campaigns about the condition are both …
Ambulatory Polysomnography (PSG) Systems Market is expected to reach US$ 516.9 Million by 2032 at a CAGR of 5.2% | FMI
The global Ambulatory Polysomnography (PSG) Systems Market is anticipated to reach a value of US$ 311.2 million in 2022 and to grow at a CAGR of 5.2% to reach US$ 516.9 million by 2032. Up to 24 channel PSG systems are expected to hold the market’s top spot with a share of about 37.0% in …
Regenerative Artificial Skin Market is expected to reach US$ 5,615.5 Million by 2032 | FMI
The global Regenerative Artificial Skin Market is expected to be valued at US$ 2,185.5 Million in 2022. This market is expanding because hospitals and clinics are increasingly in need of both temporary and permanent skin materials. The total demand for synthetic skin that is regenerative is anticipated to reach US$ 5,615.5 million in revenue by …
Heart Closure Devices Market is expected to reach a valuation of US$ 10.88 Billion by 2033 | FMI Study
The global Heart Closure Devices Market is expected to be valued at US$ 2.71 Billion in 2023. The overall demand for heart closure devices is anticipated to increase at a CAGR of 14.9% between 2023 and 2033, reaching a total of roughly US$ 10.88 Billion by 2033 due to the rise in demand for highly …
Biosimulation Market is expected to CAGR of 21.5% and be worth US$ 20.9 billion by 2032 | FMI
The Global Biosimulation Market was valued at US$ 2.6 Billion in 2021 and is expected to reach US$ 20.9 Billion by 2032, finds Future Market Insights in a recent market survey. As per the findings of the report, biosimulation software will remain pivotal for the market, as the bulk of revenue will be generated through this category. Software biosimulation will …
Pork Tapeworm Infection Treatment Market to expand at a CAGR of 8% by 2033
According to Future Market Insights, the global pork tapeworm infection treatment is expected to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion in 2033. It is expected that the market will further grow as the number of test kits and devices continues to increase. It is expected that the …
Continue reading “Pork Tapeworm Infection Treatment Market to expand at a CAGR of 8% by 2033”
Laband Syndrome Therapeutics Market is expected to garner a value of US$ 5 Billion by 2033
A recently published study by FMI expects the global Laband syndrome therapeutics market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 5 Billion is expected for the market. Rising awareness of rare diseases and increased attention to heredity-related problems in the …
Global Hyperammonemia Treatment Market is forecast to register a CAGR of 4.77% through 2033
According to a recently published study by Future Market Insights, the global hyperammonemia treatment market size is expected to reach a valuation of US$ 1,318.05 Million in 2023 and is projected to reach US$ 2,100 Million by 2033, trailing a CAGR of 4.77%. The rising prevalence of urea cycle disorders and extensive research and development …
Congenital Hyperinsulinism Treatment Market is expected to reach US$ 179.08 Million by 2033
The global Congenital Hyperinsulinism Treatment Market is expected to garner a market value of US$ 100 Million in 2023 and is expected to accumulate a market value of US$ 179.08 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Congenital Hyperinsulinism registered a CAGR of 4% in …